Short-Chain Fatty Acids and Lipopolysaccharide as Mediators Between Gut Dysbiosis and Amyloid Pathology in Alzheimer’s Disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Short-Chain Fatty Acids and Lipopolysaccharide as Mediators Between Gut Dysbiosis and Amyloid Pathology in Alzheimer’s Disease
Authors
Keywords
-
Journal
JOURNAL OF ALZHEIMERS DISEASE
Volume -, Issue -, Pages 1-15
Publisher
IOS Press
Online
2020-10-17
DOI
10.3233/jad-200306
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oxidative Stress and New Pathogenetic Mechanisms in Endothelial Dysfunction: Potential Diagnostic Biomarkers and Therapeutic Targets
- (2020) Maria Giovanna Scioli et al. Journal of Clinical Medicine
- Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors
- (2019) Stephen S. Dominy et al. Science Advances
- Prominent action of butyrate over β-hydroxybutyrate as histone deacetylase inhibitor, transcriptional modulator and anti-inflammatory molecule
- (2019) Sabrina Chriett et al. Scientific Reports
- The Short Chain Fatty Acid Butyrate Imprints an Antimicrobial Program in Macrophages
- (2019) Julie Schulthess et al. IMMUNITY
- Inflammaging and Oxidative Stress in Human Diseases: From Molecular Mechanisms to Novel Treatments
- (2019) Zuo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Microbiota-Gut-Brain Axis
- (2019) John F. Cryan et al. PHYSIOLOGICAL REVIEWS
- NLRP3 inflammasome activation drives tau pathology
- (2019) Christina Ising et al. NATURE
- Gut Microbiota is Altered in Patients with Alzheimer’s Disease
- (2018) Zhen-Qian Zhuang et al. JOURNAL OF ALZHEIMERS DISEASE
- Shifts in gut microbiota composition in an APP/PSS1 transgenic mouse model of Alzheimer's disease during lifespan
- (2018) C. Bäuerl et al. LETTERS IN APPLIED MICROBIOLOGY
- Alzheimer’s Disease-Associated β-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection
- (2018) William A. Eimer et al. NEURON
- Cytokine MIF Enhances Blood-Brain Barrier Permeability: Impact for Therapy in Ischemic Stroke
- (2018) Yu-Chuan Liu et al. Scientific Reports
- Lipopolysaccharide Associates with Amyloid Plaques, Neurons and Oligodendrocytes in Alzheimer’s Disease Brain: A Review
- (2018) Xinhua Zhan et al. Frontiers in Aging Neuroscience
- Antibiotic-induced changes in the microbiota disrupt redox dynamics in the gut
- (2018) Aspen T Reese et al. eLife
- Time and Concentration Dependent Effects of Short Chain Fatty Acids on Lipopolysaccharide- or Tumor Necrosis Factor α-Induced Endothelial Activation
- (2018) Meng Li et al. Frontiers in Pharmacology
- Role of ROS and Nutritional Antioxidants in Human Diseases
- (2018) Zewen Liu et al. Frontiers in Physiology
- Differential effects of short chain fatty acids on endothelial Nlrp3 inflammasome activation and neointima formation: Antioxidant action of butyrate
- (2018) Xinxu Yuan et al. Redox Biology
- Can a Bacterial Endotoxin be a Key Factor in the Kinetics of Amyloid Fibril Formation?
- (2018) Annalia Asti et al. JOURNAL OF ALZHEIMERS DISEASE
- Blood-Cerebrospinal Fluid Barrier Gradients in Mild Cognitive Impairment and Alzheimer's Disease: Relationship to Inflammatory Cytokines and Chemokines
- (2018) Brian R. Ott et al. Frontiers in Aging Neuroscience
- The antimicrobial protection hypothesis of Alzheimer's disease
- (2018) Robert D. Moir et al. Alzheimers & Dementia
- Endothelial cell-cell adhesion and signaling
- (2017) Camilla Cerutti et al. EXPERIMENTAL CELL RESEARCH
- Protective roles of intestinal microbiota derived short chain fatty acids in Alzheimer’s disease-type beta-amyloid neuropathological mechanisms
- (2017) Lap Ho et al. Expert Review of Neurotherapeutics
- The vicious circle of hypometabolism in neurodegenerative diseases: Ways and mechanisms of metabolic correction
- (2017) Yuri Zilberter et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly
- (2017) Annamaria Cattaneo et al. NEUROBIOLOGY OF AGING
- Protective roles of intestinal microbiota derived short chain fatty acids in Alzheimer’s disease-type beta-amyloid neuropathological mechanisms
- (2017) Lap Ho et al. Expert Review of Neurotherapeutics
- Altered NCAM Expression Associated with the Cholinergic System in Alzheimer's Disease
- (2017) Bárbara Aisa et al. JOURNAL OF ALZHEIMERS DISEASE
- Lipopolysaccharide enters the rat brain by a lipoprotein-mediated transport mechanism in physiological conditions
- (2017) Alejandra Vargas-Caraveo et al. Scientific Reports
- Gut microbiome alterations in Alzheimer’s disease
- (2017) Nicholas M. Vogt et al. Scientific Reports
- Gut microbiome–derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease
- (2016) Nathan D Mathewson et al. NATURE IMMUNOLOGY
- Gram-negative bacterial molecules associate with Alzheimer disease pathology
- (2016) Xinhua Zhan et al. NEUROLOGY
- Distribution of PSA-NCAM in normal, Alzheimer’s and Parkinson’s disease human brain
- (2016) Helen C. Murray et al. NEUROSCIENCE
- Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment
- (2016) Marina Boccardi et al. JAMA Neurology
- Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer’s disease
- (2016) Myles R. Minter et al. Scientific Reports
- Potential role of antimicrobial peptides in the early onset of Alzheimer's disease
- (2015) Mick M. Welling et al. Alzheimers & Dementia
- Neutrophils promote Alzheimer's disease–like pathology and cognitive decline via LFA-1 integrin
- (2015) Elena Zenaro et al. NATURE MEDICINE
- Host microbiota constantly control maturation and function of microglia in the CNS
- (2015) Daniel Erny et al. NATURE NEUROSCIENCE
- The effect of short-chain fatty acids on human monocyte-derived dendritic cells
- (2015) Claudia Nastasi et al. Scientific Reports
- NLRP3 Deficiency Ameliorates Neurovascular Damage in Experimental Ischemic Stroke
- (2014) Fan Yang et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Chronic Inflammation (Inflammaging) and Its Potential Contribution to Age-Associated Diseases
- (2014) C. Franceschi et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Body Fluid Cytokine Levels in Mild Cognitive Impairment and Alzheimer’s Disease: a Comparative Overview
- (2014) Frederic Brosseron et al. MOLECULAR NEUROBIOLOGY
- The gut microbiota influences blood-brain barrier permeability in mice
- (2014) V. Braniste et al. Science Translational Medicine
- Short-Chain Fatty Acids Activate GPR41 and GPR43 on Intestinal Epithelial Cells to Promote Inflammatory Responses in Mice
- (2013) Myung H. Kim et al. GASTROENTEROLOGY
- The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism
- (2013) Gijs den Besten et al. JOURNAL OF LIPID RESEARCH
- Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
- (2013) Nicholas Arpaia et al. NATURE
- Lipopolysaccharide Causes an Increase in Intestinal Tight Junction Permeability in Vitro and in Vivo by Inducing Enterocyte Membrane Expression and Localization of TLR-4 and CD14
- (2012) Shuhong Guo et al. AMERICAN JOURNAL OF PATHOLOGY
- Microbial-immune cross-talk and regulation of the immune system
- (2012) Julia Cahenzli et al. IMMUNOLOGY
- Genomic Analysis of Reactive Astrogliosis
- (2012) J. L. Zamanian et al. JOURNAL OF NEUROSCIENCE
- Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study
- (2012) Christopher M Clark et al. LANCET NEUROLOGY
- Clinical and Biomarker Changes in Alzheimer's Disease
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- CD44 Attenuates Activation of the Hippo Signaling Pathway and Is a Prime Therapeutic Target for Glioblastoma
- (2010) Y. Xu et al. CANCER RESEARCH
- Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
- (2010) R. Nau et al. CLINICAL MICROBIOLOGY REVIEWS
- Butyrate and other short-chain fatty acids as modulators of immunity: what relevance for health?
- (2010) Kees Meijer et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Predictive Value of Platelet Activation for the Rate of Cognitive Decline in Alzheimer's Disease Patients
- (2010) Konstantinos Stellos et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Increased CD44 Gene Expression in Lymphocytes Derived from Alzheimer Disease Patients
- (2010) D. Uberti et al. Neurodegenerative Diseases
- The Alzheimer's Disease-Associated Amyloid β-Protein Is an Antimicrobial Peptide
- (2010) Stephanie J. Soscia et al. PLoS One
- Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases
- (2009) Guo Nan Yin et al. BRAIN RESEARCH
- IL-1R Signaling within the Central Nervous System Regulates CXCL12 Expression at the Blood-Brain Barrier and Disease Severity during Experimental Autoimmune Encephalomyelitis
- (2009) E. E. McCandless et al. JOURNAL OF IMMUNOLOGY
- Inflammaging as a prodrome to Alzheimer's disease
- (2008) Brian Giunta et al. Journal of Neuroinflammation
- Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation
- (2008) Jae Lee et al. Journal of Neuroinflammation
- Markers of endothelial dysfunction in older subjects with late onset Alzheimer's disease or vascular dementia
- (2008) G. Zuliani et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- The role of oxidative stress and NADPH oxidase in cerebrovascular disease
- (2008) Sophocles Chrissobolis et al. TRENDS IN MOLECULAR MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More